PL1745290T3 - Użycie ferrofluidów do fenotypowania grupy krwi i dotyczące tego zastosowania - Google Patents
Użycie ferrofluidów do fenotypowania grupy krwi i dotyczące tego zastosowaniaInfo
- Publication number
- PL1745290T3 PL1745290T3 PL05767635T PL05767635T PL1745290T3 PL 1745290 T3 PL1745290 T3 PL 1745290T3 PL 05767635 T PL05767635 T PL 05767635T PL 05767635 T PL05767635 T PL 05767635T PL 1745290 T3 PL1745290 T3 PL 1745290T3
- Authority
- PL
- Poland
- Prior art keywords
- ferrofluids
- related applications
- phenotyping
- blood
- phenotyping blood
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0404853A FR2869996B1 (fr) | 2004-05-05 | 2004-05-05 | Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees |
PCT/FR2005/001101 WO2005121805A2 (fr) | 2004-05-05 | 2005-05-03 | Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees |
EP05767635.5A EP1745290B1 (fr) | 2004-05-05 | 2005-05-03 | Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1745290T3 true PL1745290T3 (pl) | 2014-01-31 |
Family
ID=34946136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05767635T PL1745290T3 (pl) | 2004-05-05 | 2005-05-03 | Użycie ferrofluidów do fenotypowania grupy krwi i dotyczące tego zastosowania |
Country Status (9)
Country | Link |
---|---|
US (1) | US8889368B2 (pl) |
EP (1) | EP1745290B1 (pl) |
JP (1) | JP4995079B2 (pl) |
AU (1) | AU2005252833A1 (pl) |
CA (1) | CA2565114A1 (pl) |
ES (1) | ES2435072T3 (pl) |
FR (1) | FR2869996B1 (pl) |
PL (1) | PL1745290T3 (pl) |
WO (1) | WO2005121805A2 (pl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8841104B2 (en) | 2010-04-21 | 2014-09-23 | Nanomr, Inc. | Methods for isolating a target analyte from a heterogeneous sample |
US20110262989A1 (en) | 2010-04-21 | 2011-10-27 | Nanomr, Inc. | Isolating a target analyte from a body fluid |
US9476812B2 (en) | 2010-04-21 | 2016-10-25 | Dna Electronics, Inc. | Methods for isolating a target analyte from a heterogeneous sample |
SE535918C2 (sv) * | 2010-06-10 | 2013-02-19 | Hemocue Ab | Detektion av magnetiskt inmärkta biologiska komponenter |
FR2963108B1 (fr) | 2010-07-21 | 2017-06-23 | Diagast | Procede magnetique d'immunodiagnostic et kit pour la mise en evidence de complexe anticorps/antigene de groupe/phenotype sanguin |
FR2963107B1 (fr) | 2010-07-21 | 2019-06-28 | Diagast | Complexe immuno-magnetique et son utilisation pour le groupage/phenotypage erythrocytaire |
US9995742B2 (en) | 2012-12-19 | 2018-06-12 | Dnae Group Holdings Limited | Sample entry |
US9599610B2 (en) | 2012-12-19 | 2017-03-21 | Dnae Group Holdings Limited | Target capture system |
US9804069B2 (en) | 2012-12-19 | 2017-10-31 | Dnae Group Holdings Limited | Methods for degrading nucleic acid |
US9434940B2 (en) | 2012-12-19 | 2016-09-06 | Dna Electronics, Inc. | Methods for universal target capture |
US9551704B2 (en) | 2012-12-19 | 2017-01-24 | Dna Electronics, Inc. | Target detection |
US10000557B2 (en) | 2012-12-19 | 2018-06-19 | Dnae Group Holdings Limited | Methods for raising antibodies |
US11753374B2 (en) | 2020-11-18 | 2023-09-12 | Southern Reserach Institute | Compounds for the treatment of acute and chronic kidney disease |
CA3199427A1 (en) | 2020-11-18 | 2022-05-27 | Mark J. Suto | Compounds for the treatment of acute and chronic kidney disease |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2461521A1 (fr) * | 1979-07-20 | 1981-02-06 | Anvar | Fluides magnetiques, notamment ferrofluides, et procede pour leur obtention |
FR2577321B1 (fr) * | 1985-02-08 | 1989-04-28 | Lapierre Yves | Dispositif et procede de mise en evidence d'agglutinats erythrocytaires |
EP0230768B1 (en) * | 1985-12-20 | 1992-03-18 | Syntex (U.S.A.) Inc. | Particle separation method |
DE68913234T2 (de) * | 1988-06-23 | 1994-09-08 | Syntex Inc | Teilchenanalyse auf mehrere Parameter. |
DE68919565T2 (de) * | 1988-07-20 | 1995-06-29 | Olympus Optical Co | Immuntestverfahren unter Verwendung magnetischer Markerteilchen. |
GR1002306B (el) * | 1990-11-09 | 1996-05-08 | Ortho Diagnostic Systems Inc. | Αναλυση και διαταξη συγκολλησεως στηλης. |
FR2679660B1 (fr) | 1991-07-22 | 1993-11-12 | Pasteur Diagnostics | Procede et dispositif magnetique d'analyse immunologique sur phase solide. |
NL1003570C2 (nl) * | 1996-07-11 | 1998-01-15 | Stichting Centraal Lab | Methode voor antigeen- en antistofbepaling in de bloedgroepserologie. |
JP2001056341A (ja) * | 1999-08-20 | 2001-02-27 | Wako Pure Chem Ind Ltd | 血液型判定方法 |
EP1409134A2 (en) | 2000-11-16 | 2004-04-21 | Prolinx, Inc. | Magnetic plate for biological separations |
FR2817967B1 (fr) | 2000-12-08 | 2003-02-28 | Diagast | Procede de magnetisation de marqueurs chimiques ou biologiques |
FR2817969B1 (fr) | 2000-12-08 | 2003-02-28 | Diagast | Dispositif et procede d'analyse immunologique |
FR2892820B1 (fr) * | 2005-11-03 | 2008-02-01 | Diagast Soc Par Actions Simpli | Procede magnetique d'immunodiagnostic pour la mise en evidence de complexe anticorps/antigene, en particulier de groupe sanguin |
CN101640822B (zh) | 2009-08-27 | 2013-01-16 | 中兴通讯股份有限公司 | 一种网元内部光纤连接自动发现的方法、装置和*** |
-
2004
- 2004-05-05 FR FR0404853A patent/FR2869996B1/fr not_active Expired - Lifetime
-
2005
- 2005-05-03 AU AU2005252833A patent/AU2005252833A1/en not_active Abandoned
- 2005-05-03 ES ES05767635T patent/ES2435072T3/es active Active
- 2005-05-03 CA CA002565114A patent/CA2565114A1/fr not_active Abandoned
- 2005-05-03 WO PCT/FR2005/001101 patent/WO2005121805A2/fr active Application Filing
- 2005-05-03 PL PL05767635T patent/PL1745290T3/pl unknown
- 2005-05-03 JP JP2007512258A patent/JP4995079B2/ja not_active Expired - Fee Related
- 2005-05-03 US US11/579,383 patent/US8889368B2/en active Active
- 2005-05-03 EP EP05767635.5A patent/EP1745290B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
ES2435072T3 (es) | 2013-12-18 |
JP2007536545A (ja) | 2007-12-13 |
WO2005121805A3 (fr) | 2006-03-23 |
US8889368B2 (en) | 2014-11-18 |
JP4995079B2 (ja) | 2012-08-08 |
US20110207151A1 (en) | 2011-08-25 |
AU2005252833A1 (en) | 2005-12-22 |
CA2565114A1 (fr) | 2005-12-22 |
WO2005121805A2 (fr) | 2005-12-22 |
FR2869996B1 (fr) | 2006-12-15 |
FR2869996A1 (fr) | 2005-11-11 |
EP1745290B1 (fr) | 2013-08-14 |
EP1745290A2 (fr) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1745290T3 (pl) | Użycie ferrofluidów do fenotypowania grupy krwi i dotyczące tego zastosowania | |
EP1756544A4 (en) | DIAGNOSIS DEVICES WITH FLOWS AND MANUFACTURING METHOD | |
IL213843A0 (en) | 4-aminotetracyclines and methods of use thereof | |
IL176958A0 (en) | Compounds and methods of use | |
IL188078A0 (en) | Nano-ionic liquids and methods of use | |
HK1097607A1 (en) | Polarizing devices and methods of making the same | |
HK1103370A1 (en) | Respiratory devices and methods of use | |
IL189771A0 (en) | Raf inhibitor compounds and methods of use thereof | |
ZA200710969B (en) | Raf inhibitor compounds and methods of use thereof | |
EP1725189A4 (en) | APPLICATIONS TO MEDICAL DEVICES OF NANOSTRUCTURED SURFACES | |
GB0404345D0 (en) | Surgical jig and methods of use | |
EP1787998A4 (en) | ANTIBODIES AND USE RELATING THERETO | |
IL178593A (en) | Specific antibodies of fcγriib and methods for their use | |
EP1833482A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
IL217350A0 (en) | 10-substituted tetracyclines and methods of use thereof | |
IL176501A0 (en) | Semiconductor devices and methods of making same | |
ZA200701820B (en) | Substituted phenylaminothiazoles and use thereof | |
AP2006003756A0 (en) | Anti-parasitic compounds and methods of their use | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
EP1720888A4 (en) | ANTIMICROBIAL GLUCOSE AND METHODS OF MAKING | |
EP1812451A4 (en) | COMPOUNDS AND METHODS OF USE THEREOF | |
ZA200705773B (en) | Thermocouple assembly and method of use | |
EP1789437A4 (en) | INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF | |
GB0421164D0 (en) | Medical devices and methods of making medical devices | |
EP1735281A4 (en) | SYNTHESIS OF INDENOISOQUINOLINIUMS AND TECHNIQUES OF USE |